Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

NSPR Insider Trading

InspireMD, Inc. | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at InspireMD, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-05-21 21:16 2025-01-27 Gleason Shane Thomas Officer - Chief Commercial Officer SELL $2.22 85,295 $189,594 1,053,882 -7.5%
2026-05-15 20:05 2026-05-13 Stuka Paul Director BUY $1.16 15,000 $17,325 647,871 +2.4%
2026-05-13 21:00 2026-05-12 Slosman Marvin Director, Officer - CEO and President BUY $1.20 21,000 $25,200 3,556,658 +0.6%
2026-05-12 23:35 2026-05-08 Stuka Paul Director BUY $1.16 75,626 $88,029 632,871 +13.6%
2026-05-08 21:05 2026-05-06 Stuka Paul Director BUY $1.14 7,895 $9,033 531,599 +1.5%
2026-05-08 21:08 2026-05-06 Ward Scott R. Director BUY $1.15 89,250 $102,638 237,096 +60.4%
2026-05-08 21:03 2026-05-07 ROUBIN GARY S Director BUY $1.18 90,000 $106,200 834,478 +12.1%
2026-02-24 00:05 2025-12-09 Stuka Paul Director BUY $1.81 2,710 $4,905 391,628 +0.7%
2026-02-03 01:01 2026-01-15 Gleason Shane Thomas Officer - Chief Commercial Officer SELL $1.62 61,194 $99,330 1,139,177 -5.1%
2025-12-12 00:05 2025-12-09 Stuka Paul Director BUY $1.81 5,073 $9,182 391,628 +1.3%
2025-12-09 00:05 2025-12-05 Stuka Paul Director BUY $1.86 5,073 $9,436 388,918 +1.3%
2025-12-06 00:05 2025-12-04 Stuka Paul Director BUY $1.85 10,130 $18,741 383,845 +2.7%
2025-11-14 00:05 2025-11-12 Stuka Paul Director BUY $1.62 13,431 $21,758 373,715 +3.7%
2025-08-02 00:00 2025-07-30 Slosman Marvin Director, Officer - CEO and President BUY $2.42 10,330 $24,999 2,420,866 +0.4%
2025-08-02 00:00 2025-07-30 Stuka Paul Director BUY $2.42 20,661 $50,000 444,195 +4.9%
2025-08-02 00:00 2025-07-30 Kester Thomas J Director BUY $2.42 30,991 $74,998 420,758 +8.0%
2025-08-02 00:00 2025-07-30 ROUBIN GARY S Director BUY $2.42 41,322 $99,999 608,425 +7.3%
2023-12-05 00:15 2023-11-30 ROUBIN GARY S Director BUY $2.53 50,000 $126,540 438,902 +12.9%
2023-05-16 23:16 2023-05-12 Stuka Paul Director BUY $1.63 175,000 $285,723 248,534 +238.0%
2023-05-16 23:16 2023-05-12 Kester Thomas J Director BUY $1.63 61,249 $100,001 108,590 +129.4%
2023-05-16 23:15 2023-05-12 BERMAN MICHAEL Director BUY $1.63 122,497 $200,001 122,497 +100.0%
2023-05-16 23:15 2023-05-12 ROUBIN GARY S Director BUY $1.63 61,249 $100,001 233,545 +35.5%
2022-08-22 23:30 2022-08-18 ROUBIN GARY S Director BUY $1.91 35,500 $67,770 164,194 +27.6%
2021-12-30 17:00 2021-12-28 ROUBIN GARY S Director BUY $3.08 16,393 $50,436 128,694 +14.6%
2021-12-03 02:30 2021-12-01 Stuka Paul Director BUY $3.51 12,037 $42,288 73,534 +19.6%
2021-12-01 01:53 2021-11-29 Stuka Paul Director BUY $3.55 21,549 $76,499 61,497 +53.9%
2021-11-30 00:05 2021-11-26 Stuka Paul Director BUY $3.55 1,200 $4,260 39,948 +3.1%
2021-11-27 00:05 2021-11-24 Stuka Paul Director BUY $3.55 18,328 $65,064 38,748 +89.8%
2021-11-24 03:34 2021-11-22 Stuka Paul Director BUY $3.54 20,392 $72,147 20,420 +72,828.6%
2021-11-19 00:05 2021-11-17 ROUBIN GARY S Director BUY $3.86 25,930 $99,960 112,301 +30.0%
2021-08-27 00:00 2021-08-25 ROUBIN GARY S Director BUY $4.19 22,249 $93,246 69,123 +47.5%
2021-02-10 15:13 2021-02-08 Slosman Marvin Director, Officer - CEO and President BUY $0.62 40,320 $24,998 1,453,538 +2.9%
2021-02-10 15:13 2021-02-08 Kester Thomas J Director BUY $0.62 120,960 $74,995 331,593 +57.4%
2021-02-10 15:11 2021-02-08 BERMAN MICHAEL Director BUY $0.62 80,640 $49,997 241,275 +50.2%
2021-02-10 15:11 2021-02-08 ROUBIN GARY S Director BUY $0.62 241,930 $149,997 703,103 +52.5%
2020-10-19 17:18 2020-10-16 ROUBIN GARY S Director BUY $0.45 222,223 $100,000 461,173 +93.0%
2020-06-09 20:30 2020-06-05 Slosman Marvin Director, Officer - CEO and President BUY $0.45 55,550 $24,998 237,931 +30.5%
2020-06-05 18:59 2020-06-03 Kester Thomas J Director BUY $0.42 50,000 $20,750 52,600 +1,923.1%
2018-12-12 00:07 2018-12-11 Stuka Paul Director SELL $0.18 65 $12 12,746 -0.5%
2018-11-26 14:10 2018-11-21 Kester Thomas J Director SELL $0.21 8 $2 0 -100.0%
2016-03-23 21:06 2016-03-21 Rogers Campbell Director BUY $0.59 8,474 $5,000 8,475 +847,400.0%
2016-03-23 21:05 2016-03-21 Stuka Paul Director BUY $0.59 127,119 $75,000 267,060 +90.8%
2016-03-23 21:06 2016-03-21 LOUGHLIN JAMES J Director BUY $0.59 50,000 $29,500 51,501 +3,331.1%
2016-03-23 21:06 2016-03-21 BARER SOL J Director BUY $0.59 847,458 $500,000 1,141,690 +288.0%
2015-03-11 23:49 2015-03-09 Stuka Paul Director BUY $0.00 625,000 $0 1,370,204 +83.9%
2015-03-12 00:02 2015-03-09 BARER SOL J Director BUY $0.00 2,500,000 $0 2,942,308 +565.2%
2015-03-11 23:56 2015-03-09 MILINAZZO ALAN Director, Officer - President and CEO BUY $0.00 125,000 $0 1,423,436 +9.6%
2014-11-12 14:16 2014-11-07 Olson Eric L. Officer - VP of Global Sales Operations BUY $0.00 115,385 $0 147,163 +363.1%
2014-11-12 14:15 2014-11-07 Barry James J Director, Officer - Executive VP and COO BUY $0.00 19,231 $0 169,231 +12.8%
2014-11-11 01:10 2014-11-07 BARER SOL J Director BUY $0.00 192,308 $0 442,308 +76.9%
SHOW ENTRIES

How to Interpret $NSPR Trades

Not every insider transaction in InspireMD, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $NSPR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for NSPR

Insider activity data for InspireMD, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $NSPR, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.